表纸
市场调查报告书

干眼症症候群治疗药的全球市场: 各产品类型,各流通管道,各地区的市场规模,占有率,展望,机会分析:2020年~2027年

Dry Eye Syndrome Treatment Market, by Product Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品编码 948416
出版日期 内容资讯 英文 187 Pages
商品交期: 2-3个工作天内
价格
干眼症症候群治疗药的全球市场: 各产品类型,各流通管道,各地区的市场规模,占有率,展望,机会分析:2020年~2027年 Dry Eye Syndrome Treatment Market, by Product Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年07月07日内容资讯: 英文 187 Pages
简介

干眼症症候群(DES),又称干性角膜炎或角膜干燥症,伴随眼球表面的损伤,泪液薄膜的不稳定性,视觉障碍等症状。由于现在新的干眼症治疗药投入市场,有许多核准申请中的产品,预计今后市场将踏实持续成长。

本报告提供全球金属奈米粒子和金属氧化物奈米粒子的市场调查,市场力学和法规,新型冠状病毒感染疾病(COVID-19)大流行的影响,各产品类型,各用途,各地区的分析,竞争情形与企业简介等资讯。

目录

第1章 调查的目的与前提

第2章 市场展望

  • 报告概要
  • 市场定义和范围
  • 摘要整理
  • 市场区隔: 各产品类型
  • 市场区隔:各流通管道
  • 市场区隔:各地区
    • 市场机会蓝图

第3章 市场力学,法规,趋势分析

  • 市场力学
  • 成长促进因素
  • 成长阻碍因素
  • 市场机会
  • 影响分析
  • 技术的进步
  • PEST分析
  • 显微镜比较
  • 波特的五力分析
  • COVID-19大流行的影响分析

第4章 COVID-19大流行的影响

第5章 市场分析: 各产品类型

  • 简介
  • 市场占有率分析:2019年和2027年
  • 与前一年同期比较成长率分析:2017年-2027年
  • 市场区隔趋势
    • Cyclosporine
    • 口服类固醇
    • 人工眼泪
    • Omega补充品
    • 眼药袋
    • 其他

第6章 市场分析: 各流通管道

  • 简介
  • 市场占有率分析:2019年和2027年
  • 与前一年同期比较成长率分析:2017年-2027年
  • 市场区隔趋势
    • 医院药局
    • 零售药局
    • 超级市场/大卖场
    • 其他商店
    • 线上药局

第7章 市场分析: 各地区

  • 简介
  • 市场占有率分析:2019年和2027年
  • 与前一年同期比较成长率分析:2017年-2027年
  • 市场区隔趋势
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韩国
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 非洲
    • 北非
    • 中非
    • 南非
  • 中东
    • GCC
    • 以色列
    • 其他

第8章 竞争情形

  • 企业简介
    • Allergan
    • Novartis AG
    • Bausch Health Companies,Inc.
    • Johnson and Johnson Vision Care Inc.
    • I-Med Pharma Inc
    • Santen Pharmaceuticals Co. Ltd.
    • AFT Pharmaceuticals
    • Novaliq GmBH
    • Otsuka Pharmaceutical Co. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.

第9章

目录

Title:
Dry Eye Syndrome Treatment Market, by Product Type (Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plug, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Supermarket/ Hypermarket, Other Stores, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Dry eye syndrome (DES) is also known as keratisis sicca and keratoconjunctivitis sicca. Patients suffering from DES show damage to the ocular surface, instability in the tear film, and visual disturbance. Tear film covers the ocular surface which is made up of three intertwined layers, a superficial lipid layer produced by meibomian glands assist in reducing tear evaporation and uniform tear spreading, middle thick aqueous layer produced from lacrimal glands, and the innermost hydrophilic mucin layer produced from goblet cells of conjunctiva and epithelium of ocular surface.

Market Dynamics

New dry eye therapies are introduced in the market with several new medications in the pipeline seeking approval. Strong product pipeline offers great market growth opportunity as approval of numerous pipeline products is expected to drive the market growth during the forecast period. In August 2018, Sun Pharma received approval for Cequa (cyclosporine ophthalmic solution) 0.09% from the U.S. FDA. The drug is indicated to increase tear production in patients with dry eye disease. Cequa is the only approved cyclosporine product that incorporates a nanomicellar technology and allows better penetration of the active molecule into the ocular tissues. Moreover, in January 2018, Shire plc. received FDA approval for Xiidra (lifitegrast ophthalmic solution 5%), a twice-daily eye drop solution for dry eye disease in adults in Canada. The drug was initially approved by the U.S. FDA in 2016. Thus, product approvals are expected to provide an opportunity for manufacturers to introduce novel therapies in the market.

Key features of the study:

  • This report provides in-depth analysis of the dry eye syndrome treatment market, market size (US$ Million) and compound annual growth rate (CAGR (%)) for the forecast period, 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global dry eye syndrome treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study are Allergan Plc., Novartis AG, Bausch Health Companies, Inc., Johnson and Johnson Vision Care Inc., I-Med Pharma Inc., Santen Pharmaceuticals Co. Ltd., AFT Pharmaceuticals, Novaliq GmBH, Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, end user upgrades, market expansion, and marketing tactics
  • The global dry eye syndrome treatment market report caters to various stakeholders in this industry, including investors, drug/product manufacturers, distributors and suppliers for dry eye Syndrome Treatment Market, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the dry eye syndrome treatment market would provide stakeholders vital inputs to make strategic decisions accordingly.

Detailed Segmentation:

  • Global Dry Eye Syndrome Treatment Market, By Product Type :
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
  • Global Dry Eye Syndrome Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
  • Global Dry Eye Syndrome Treatment Market, By Region:
    • North America
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country:
    • U.S.
    • Canada
    • Europe
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Latin America
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
  • Allergan
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
  • Bausch Health Companies, Inc.
  • Johnson and Johnson Vision Care Inc.
  • I-Med Pharma Inc
  • Santen Pharmaceuticals Co. Ltd.
  • AFT Pharmaceuticals
  • Novaliq GmBH
  • Otsuka Pharmaceutical Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Technological Evolution
  • PEST Analysis
  • Microscope Comparison
  • Porters Analysis
  • COVID-19 Impact Analysis

4. Global Dry Eye Syndrome Treatment Market, Impact of COVID-19 Pandemic

  • COVID19 Impact
  • Economic Impact
  • Demand and Supply Impact Analysis

5. Global Dry Eye Syndrome Treatment Market, By Product Type, 2020-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Cyclosporine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Oral Corticosteroid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Artificial Tears
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Omega Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Punctual Bags
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

6. Global Dry Eye Syndrome Treatment Market, By Distribution Channel, 2020-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Supermarket/ Hypermarket
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Other Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

7. Global Dry Eye Syndrome Treatment Market, By Region, 2020-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, By Region, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Region, 2017-2027
  • North America
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
  • U.S.
  • Canada
  • Europe
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Africa
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country/Region, 2016-2027 (US$ Bn)
  • Central Africa
  • South Africa
  • North Africa
  • Middle East
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East

8. Competitive Landscape

  • Company Profiles
  • Allergan
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bausch Health Companies, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson and Johnson Vision Care Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • I-Med Pharma Inc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Santen Pharmaceuticals Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AFT Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novaliq GmBH
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Otsuka Pharmaceutical Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact